Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tango Therapeutics Inc (NQ: TNGX ) 6.890 +0.340 (+5.19%) Streaming Delayed Price Updated: 12:13 PM EDT, Oct 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Tango Therapeutics Inc Tango Therapeutics to Participate in Upcoming Investor Conferences August 28, 2024 From Tango Therapeutics, Inc. Via Business Wire Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights August 07, 2024 From Tango Therapeutics, Inc. Via Business Wire Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From Tango Therapeutics, Inc. Via Business Wire Tango Therapeutics Announces Discontinuation of TNG348 Program May 23, 2024 From Tango Therapeutics Via Business Wire Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights May 08, 2024 From Tango Therapeutics, Inc. Via Business Wire Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 01, 2024 From Tango Therapeutics, Inc. Via Business Wire Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights March 18, 2024 From Tango Therapeutics, Inc. Via Business Wire Tango Therapeutics to Participate in Upcoming Investor Conferences March 06, 2024 From Tango Therapeutics, Inc. Via Business Wire Pancreatic Cancer Treatments Poised for Major Advances in 2024 February 07, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:INCY),(NASDAQ:TNGX),(NASDAQ:RYZB),(NYSE:BMY) EQNX::TICKER_END Via FinancialNewsMedia Special Purpose Acquisition Companies: The Briscoe Law Firm, PLLC Announce Investigation into the following SPACs March 08, 2023 From The Briscoe Law Firm, PLLC Via Business Wire Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Tango Therapeutics, Inc (TNGX) Investigation February 21, 2023 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire HOOKIPA Pharma Appoints Katia Schlienger, M.D., Ph.D., Chief Medical Officer and Malte Peters, M.D., to Board of Directors December 15, 2022 From HOOKIPA Pharma Inc. Via GlobeNewswire Tango Therapeutics Announces Presentation of Preclinical Data on Lead Program and Discovery Platform in Five Abstracts Accepted at AACR-NCI-EORTC 2021 September 30, 2021 From Tango Therapeutics, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.